On April 3, 2023 Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on the development of novel immunotherapies in oncology that address cancer immune resistance, reported that Shawn Iadonato, Ph.D., CEO will present at the 22nd Annual Needham Healthcare Conference, being held virtually from April 17-20, 2023 (Press release, Kineta, APR 3, 2023, View Source;utm_medium=rss&utm_campaign=kineta-to-present-at-22nd-annual-needham-healthcare-conference [SID1234629750]). Company management will also be available for virtual one-on-one meetings.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Event: 22nd Annual Needham Virtual Healthcare Conference
Date: Tuesday April 18, 2023
Time: 12:45 – 1:25 P.M. Eastern Time
The webcast presentation replay will be available for viewing on the Events & Presentations section of the Company’s website.